1. Home
  2. ARAY vs ENTA Comparison

ARAY vs ENTA Comparison

Compare ARAY & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARAY
  • ENTA
  • Stock Information
  • Founded
  • ARAY 1990
  • ENTA 1995
  • Country
  • ARAY United States
  • ENTA United States
  • Employees
  • ARAY N/A
  • ENTA N/A
  • Industry
  • ARAY Medical/Dental Instruments
  • ENTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • ARAY Health Care
  • ENTA Health Care
  • Exchange
  • ARAY Nasdaq
  • ENTA Nasdaq
  • Market Cap
  • ARAY 170.1M
  • ENTA 164.6M
  • IPO Year
  • ARAY 2007
  • ENTA 2013
  • Fundamental
  • Price
  • ARAY $1.57
  • ENTA $8.28
  • Analyst Decision
  • ARAY Strong Buy
  • ENTA Strong Buy
  • Analyst Count
  • ARAY 1
  • ENTA 4
  • Target Price
  • ARAY $5.00
  • ENTA $22.25
  • AVG Volume (30 Days)
  • ARAY 742.6K
  • ENTA 158.9K
  • Earning Date
  • ARAY 11-05-2025
  • ENTA 08-11-2025
  • Dividend Yield
  • ARAY N/A
  • ENTA N/A
  • EPS Growth
  • ARAY N/A
  • ENTA N/A
  • EPS
  • ARAY N/A
  • ENTA N/A
  • Revenue
  • ARAY $458,505,000.00
  • ENTA $64,806,000.00
  • Revenue This Year
  • ARAY $5.84
  • ENTA N/A
  • Revenue Next Year
  • ARAY $3.90
  • ENTA $1.65
  • P/E Ratio
  • ARAY N/A
  • ENTA N/A
  • Revenue Growth
  • ARAY 2.68
  • ENTA N/A
  • 52 Week Low
  • ARAY $1.14
  • ENTA $4.09
  • 52 Week High
  • ARAY $2.95
  • ENTA $13.37
  • Technical
  • Relative Strength Index (RSI)
  • ARAY 56.74
  • ENTA 49.11
  • Support Level
  • ARAY $1.54
  • ENTA $8.25
  • Resistance Level
  • ARAY $1.64
  • ENTA $9.08
  • Average True Range (ATR)
  • ARAY 0.06
  • ENTA 0.44
  • MACD
  • ARAY -0.00
  • ENTA -0.08
  • Stochastic Oscillator
  • ARAY 57.89
  • ENTA 3.78

About ARAY Accuray Incorporated

Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

Share on Social Networks: